Monoclonal antibodies generated against an affinity-labeled immune complex of an anti-bile acid metabolite antibody: an approach to noncompetitive hapten immunoassays based on anti-idiotype or anti-metatype antibodies.
Conventional immunoassays for haptens such as steroids and synthetic drugs are dependent on the competitive reaction between an unlabeled antigen (analyte) and a labeled antigen against a limited amount of anti-hapten antibody. Although noncompetitive immunoassay procedures such as two-site immunometric assays offer a much higher sensitivity, direct application of this principle to haptens has been difficult due to their small molecular mass precluding simultaneous binding by two antibody molecules. Here, we have attempted to develop a noncompetitive immunoassay system based on anti-idiotype or anti-metatype antibodies. Ursodeoxycholic acid 7-N-acetylglucosaminide (UDCA 7-NAG), which is a bile acid metabolite (molecular weight, 595.8), was selected as the model hapten. A/J mice were immunized with a monoclonal antibody against UDCA 7-NAG, which had been affinity-labeled with a relevant hapten derivative. The fusion between the immune spleen cells and P3/NS1/1-Ag4-1 myeloma cells yielded four kinds of alpha-type and two kinds of beta-type monoclonal anti-idiotype antibodies, each recognizing the framework region and paratope of the anti-hapten antibody. The use of a selected combination between alpha-type and beta-type antibodies together with the anti-hapten antibody provided a noncompetitive assay system with a subfemtomole order sensitivity (detection limit, 118 amol) and a practical specificity.
Kobayashi
N
N
Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Aoba-ku, 980-8578, Sendai, Japan.
Oiwa
H
H
Kubota
K
K
Sakoda
S
S
Goto
J
J
D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism; D000345:Affinity Labels; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis*; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D000936:Antigen-Antibody Complex / Q000276:immunology*; D001667:Binding, Competitive; D019921:Biotinylation; D002459:Cell Fusion; D006241:Haptens; D007118:Immunoassay / Q000379:methods* / Q000706:statistics & numerical data; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D012680:Sensitivity and Specificity; D014580:Ursodeoxycholic Acid / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism
D000345:Affinity Labels; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D006241:Haptens; C060582:ursodeoxycholic acid N-acetylglucosaminide; D014580:Ursodeoxycholic Acid; D000117:Acetylglucosamine